ASR Vermogensbeheer N.V. purchased a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 131,503 shares of the real estate investment trust's stock, valued at approximately $2,659,000.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. TCTC Holdings LLC raised its position in Healthpeak Properties by 124.3% in the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 751 shares during the period. Future Financial Wealth Managment LLC acquired a new stake in shares of Healthpeak Properties in the first quarter valued at $30,000. S.A. Mason LLC raised its holdings in shares of Healthpeak Properties by 160.9% in the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after buying an additional 925 shares during the period. Covestor Ltd raised its holdings in shares of Healthpeak Properties by 173.8% in the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock valued at $37,000 after buying an additional 1,152 shares during the period. Finally, Beacon Capital Management LLC lifted its stake in Healthpeak Properties by 138.3% during the 1st quarter. Beacon Capital Management LLC now owns 1,816 shares of the real estate investment trust's stock worth $37,000 after acquiring an additional 1,054 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research firms have weighed in on DOC. Evercore ISI cut their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Wall Street Zen downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Robert W. Baird set a $21.00 price target on shares of Healthpeak Properties and gave the company an "outperform" rating in a research report on Wednesday, July 30th. Wells Fargo & Company dropped their price target on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research note on Monday, June 2nd. Finally, Wedbush reduced their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and a consensus price target of $23.00.
Check Out Our Latest Analysis on Healthpeak Properties
Insider Activity at Healthpeak Properties
In related news, Director Tommy G. Thompson acquired 5,777 shares of the business's stock in a transaction on Wednesday, May 28th. The shares were bought at an average price of $17.27 per share, with a total value of $99,768.79. Following the completion of the acquisition, the director owned 144,290 shares in the company, valued at $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Scott M. Brinker bought 2,930 shares of the stock in a transaction dated Thursday, July 31st. The stock was bought at an average price of $17.06 per share, with a total value of $49,985.80. Following the acquisition, the chief executive officer owned 210,416 shares in the company, valued at approximately $3,589,696.96. This represents a 1.41% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 14,560 shares of company stock worth $249,898 over the last quarter. 0.23% of the stock is currently owned by insiders.
Healthpeak Properties Stock Performance
NYSE:DOC opened at $16.95 on Friday. Healthpeak Properties, Inc. has a 12 month low of $16.64 and a 12 month high of $23.26. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. The firm has a market capitalization of $11.78 billion, a PE ratio of 70.61, a price-to-earnings-growth ratio of 2.15 and a beta of 1.05. The business's fifty day moving average price is $17.66 and its 200 day moving average price is $18.64.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%. The business had revenue of $694.35 million during the quarter, compared to analysts' expectations of $697.14 million. During the same period in the prior year, the firm posted $0.45 EPS. The business's quarterly revenue was down .2% compared to the same quarter last year. On average, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The business also recently declared a monthly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Friday, September 19th will be paid a $0.1017 dividend. This represents a c) annualized dividend and a yield of 7.2%. The ex-dividend date is Friday, September 19th. Healthpeak Properties's dividend payout ratio is currently 508.33%.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.